CN102552711B - Traditional Chinese medicine composition for treating hypertension - Google Patents
Traditional Chinese medicine composition for treating hypertension Download PDFInfo
- Publication number
- CN102552711B CN102552711B CN 201210036793 CN201210036793A CN102552711B CN 102552711 B CN102552711 B CN 102552711B CN 201210036793 CN201210036793 CN 201210036793 CN 201210036793 A CN201210036793 A CN 201210036793A CN 102552711 B CN102552711 B CN 102552711B
- Authority
- CN
- China
- Prior art keywords
- parts
- hypertension
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention relates to a Chinese medicinal composition for treating hypertension. The Chinese medicinal composition is characterized by being prepared from the following components in part by weight: 6 to 10 parts of leech, 2 to 4 parts of gastrodia elata, 10 to 20 parts of sea-ear shell, 8 to 10 parts of uncaria rhynchophylla, 9 to 10 parts of wild chrysanthemum, 3 to 5 parts of palmate-leaved morning glory, 6 to 8 parts of polygonum multiflorum, 1 to 2 parts of motherwort fruit, 10 to 15 parts of tree peony bark, 4 to 8 parts of astragalus, 9 to 16 parts of tuckahoe, 4 to 8 parts of mulberry leaf and 5 to 9 parts of mother of pearl. The Chinese medicinal composition has an obvious curative effect on the hypertension and complication caused by the hypertension.
Description
Technical field the present invention relates to a kind of pharmaceutical composition, relates to more specifically a kind of hypertensive Chinese medicine composition for the treatment of.
Background technology
Hypertension (Hypertension) is a kind of global common disease, and the prevalence of countries in the world is up to 10%-20%, and can cause the pathological changes of cerebrovascular, heart, kidney, and agnogenic hyperpietic claims essential hypertension or secondary hypertension.In China, the main directly complication of hypertension is cerebrovascular, especially cerebral hemorrhage.The primary hypertension patient that one group of 312 example is in hospital was followed up a case by regular visits to for a long time through 15 years-18 years, due to the heart, brain, dead 97 examples of kidney complication, accounted for 74.6% of whole causes of the death.In 596 routine senile hypertensions follow-up observation in perspective 27 months research, the heart, cerebrovascular accumulate incidence are 68.79%, and the cerebrovascular accumulate incidence is 36.91%.Research shows, blood pressure is higher, and the incidence rate of complication is also higher.
At present, if the drug main Western medicine of Hypertension disease.Because doctor trained in Western medicine can only be controlled, can not thoroughly cure hypertension, hyperlipidemia, hyperglycemia, therefore must take medicine all the life, the burden but also the long-term taking that have not only greatly increased the weight of the patient also can have side effects.
Summary of the invention
The present invention, for overcoming above-mentioned the deficiencies in the prior art, provides a kind of hypertensive Chinese medicine composition for the treatment of, and selects Chinese herbal medicine, has an antihypertensive effect obvious, the characteristics that side effect is little.
The present invention adopts following technical scheme to realize:
A kind ofly treating hypertensive Chinese medicine composition, it is characterized in that, is to be made by the component of following parts by weight: Hirudo 6-10 part, Rhizoma Gastrodiae 2-4 part, Concha Haliotidis 10-20 part, Ramulus Uncariae Cum Uncis 8-10 part, Flos Chrysanthemi Indici 9-10 part, Radix seu Herba Tetrastigmatis Hypoglauci 3-5 part, Radix Polygoni Multiflori 6-8 part, Fructus Leonuri 1-2 part, Cortex Moutan 10-15 part, Radix Astragali 4-8 part, Poria 9-16 part, Folium Mori 4-8 part, Concha Margaritifera 5-9 part.
Further, a kind ofly treat hypertensive Chinese medicine composition, it is characterized in that: the parts by weight of each component are as follows: 8 parts of Hirudos, 3 parts, Rhizoma Gastrodiae, 15 parts of Concha Haliotidis, 9 parts of Ramulus Uncariae Cum Unciss, 9 parts of Flos Chrysanthemi Indicis, 4 parts of Radix seu Herba Tetrastigmatis Hypoglaucis, 7 parts of Radix Polygoni Multiflori, 1 part of Fructus Leonuri, 12 parts of Cortex Moutans, 5 parts of the Radixs Astragali, 12 parts, Poria, 6 parts, Folium Mori, 7 parts of Concha Margaritiferas.
Wherein in each component of the present invention:
Hirudo, the popular name Hirudo, be the medicinal aquatic animal of the traditional special type of China, its dry products is concocted the rear traditional Chinese medical science and is used as medicine, and has the effects such as treatment apoplexy, hypertension, the clear stasis of blood, traumatic injury.
Rhizoma Gastrodiae, Rhizoma Gastrodiae has calmness, analgesia, anticonvulsant action; Can increase cerebral blood flow, reduce cerebral vascular resistance, slightly shrink cerebrovascular, increase the coronary vasodilator flow; Can reduce blood pressure, decreased heart rate, have protective effect to myocardial ischemia; Gastrodia elata polysaccharide has immunocompetence.
Flos Chrysanthemi Indici, be slightly cold, hot, bitter; Return lung, Liver Channel.Heat-clearing and toxic substances removing; The dispelling wind suppressing the hyperactive liver.
Fructus Leonuri, acrid in the mouth, hardship, cold nature.GUIXIN bag, Liver Channel.
Preparation and instructions of taking: the impurity place to go by each crude drug, be decocted in water for oral dose, potion on the one.It within ten days, is a course for the treatment of.
After taking three courses for the treatment of, clinical observation shows:
The treatment standard: 1 cures: high pressure≤140mmHg, and low pressure≤90mmHg, drug withdrawal blood pressure does not after two months rebound;
2 is effective: high pressure≤140mmHg, and low pressure≤90mmHg, drug withdrawal blood pressure after two months has a rebound;
3 is invalid;
Adopt hypertension therapy clinical statistics of the present invention: treatment hypertension 200 examples, wherein male 49-60 year totally 110 examples, account for 44 examples more than 60 years old, account for 46 examples in women 45-67 year.After taking three courses for the treatment of, clinical treatment 200 examples, cure 131 examples, and drug withdrawal blood pressure does not after two months normally rebound, the routine drug withdrawal of cure rate 65.5%, 69 after 2 months blood pressure have a rebound, effective percentage 34.5%, total effective rate 100%, inefficiency 0.
The specific embodiment
Embodiment 1:
By Hirudo 6g, Rhizoma Gastrodiae 2g, Concha Haliotidis 10g, Ramulus Uncariae Cum Uncis 8g, Flos Chrysanthemi Indici 9g, Radix seu Herba Tetrastigmatis Hypoglauci 3g, Radix Polygoni Multiflori 6g, Fructus Leonuri 1g, Cortex Moutan 10g, Radix Astragali 4g, Poria 9g, Folium Mori 4g, Concha Margaritifera 5g, add water 1000ml and decoct, and the elimination slag becomes the 500ml decoction, takes every day once, within ten days, is a course for the treatment of.
Embodiment 2:
By Hirudo 10g, Rhizoma Gastrodiae 4g, Concha Haliotidis 20g, Ramulus Uncariae Cum Uncis 10g, Flos Chrysanthemi Indici 10g, Radix seu Herba Tetrastigmatis Hypoglauci 5g, Radix Polygoni Multiflori 8g, Fructus Leonuri 2g, Cortex Moutan 15g, Radix Astragali 8g, Poria 16g, Folium Mori 8g, Concha Margaritifera 9g, add water 1000ml and decoct, and the elimination slag becomes the 500ml decoction, takes every day once, within ten days, is a course for the treatment of.
Embodiment 3:
By Hirudo 8g, Rhizoma Gastrodiae 3g, Concha Haliotidis 15g, Ramulus Uncariae Cum Uncis 9g, Flos Chrysanthemi Indici 9g, Radix seu Herba Tetrastigmatis Hypoglauci 4g, Radix Polygoni Multiflori 7g, Fructus Leonuri 1g, Cortex Moutan 12g, Radix Astragali 5g, Poria 12g, Folium Mori 6g, Concha Margaritifera 7g, add water 1000ml and decoct, and the elimination slag becomes the 500ml decoction, takes every day once, within ten days, is a course for the treatment of.
Claims (2)
1. the hypertensive Chinese medicine composition for the treatment of, is characterized in that, is to be made by the component of following parts by weight: Hirudo 6-10 part, Rhizoma Gastrodiae 2-4 part, Concha Haliotidis 10-20 part, Ramulus Uncariae Cum Uncis 8-10 part, Flos Chrysanthemi Indici 9-10 part, Radix seu Herba Tetrastigmatis Hypoglauci 3-5 part, Radix Polygoni Multiflori 6-8 part, Fructus Leonuri 1-2 part, Cortex Moutan 10-15 part, Radix Astragali 4-8 part, Poria 9-16 part, Folium Mori 4-8 part, Concha Margaritifera 5-9 part.
2. the hypertensive Chinese medicine composition for the treatment of as claimed in claim 1, it is characterized in that: the parts by weight of each component are as follows: 8 parts of Hirudos, 3 parts, Rhizoma Gastrodiae, 15 parts of Concha Haliotidis, 9 parts of Ramulus Uncariae Cum Unciss, 9 parts of Flos Chrysanthemi Indicis, 4 parts of Radix seu Herba Tetrastigmatis Hypoglaucis, 7 parts of Radix Polygoni Multiflori, 1 part of Fructus Leonuri, 12 parts of Cortex Moutans, 5 parts of the Radixs Astragali, 12 parts, Poria, 6 parts, Folium Mori, 7 parts of Concha Margaritiferas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210036793 CN102552711B (en) | 2012-02-20 | 2012-02-20 | Traditional Chinese medicine composition for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210036793 CN102552711B (en) | 2012-02-20 | 2012-02-20 | Traditional Chinese medicine composition for treating hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552711A CN102552711A (en) | 2012-07-11 |
| CN102552711B true CN102552711B (en) | 2013-12-18 |
Family
ID=46400165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210036793 Active CN102552711B (en) | 2012-02-20 | 2012-02-20 | Traditional Chinese medicine composition for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552711B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104224921A (en) * | 2014-09-26 | 2014-12-24 | 刘赏清 | Traditional Chinese medicine composition for treating high blood pressure |
| CN106075102A (en) * | 2016-07-29 | 2016-11-09 | 苏州科豪生物制品有限公司 | A kind of for foot bath soup treating hypertension and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390580A (en) * | 2002-05-16 | 2003-01-15 | 段登奎 | 'Naoxinkang' capsule for treating hypertension |
-
2012
- 2012-02-20 CN CN 201210036793 patent/CN102552711B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390580A (en) * | 2002-05-16 | 2003-01-15 | 段登奎 | 'Naoxinkang' capsule for treating hypertension |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552711A (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN104107349A (en) | Chinese herbal medicine for three-hypers patients, and its administration method | |
| CN105012452A (en) | New application of clausena lansium leaves | |
| CN102302673B (en) | Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN) | |
| CN102626478A (en) | Externally used Chinese herbal medicine compound for treating lumbar muscle strain for years | |
| CN105055915A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN101130054A (en) | Traditional Chinese medicine for treating essential resistance of turbid phlegm type vertigo | |
| CN102552711B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN100428944C (en) | Compound traditional Chinese medicine for improving eyesight and its prepn. method | |
| CN102204978B (en) | Medicinal composition for treating cancer pain and preparation thereof | |
| CN103735871A (en) | Chinese medicinal composition for treating neurasthenia and preparation method thereof | |
| CN102526511B (en) | Chinese medicinal composition for treating hypertension | |
| CN103735755A (en) | Traditional Chinese medicinal composition for treating hypertension and preparation method thereof | |
| CN103446384A (en) | Traditional Chinese medicine composition for decreasing blood sugar | |
| CN106334171A (en) | Traditional Chinese medicine preparation for repairing liver damage and preparation method thereof | |
| CN102380048B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN102430073B (en) | Medicinal composition for treating peptic ulcer | |
| CN111529597A (en) | Traditional Chinese medicine composition for gout and/or hyperuricemia | |
| CN102357207B (en) | Traditional Chinese medicine composition for curing hypertension | |
| CN101912460B (en) | Preparation method for improving ginsenoside-containing Chinese medicinal extract quality | |
| CN105434598A (en) | Traditional Chinese medicine composition for preventing and treating hypertension, preparation method thereof and preparation | |
| CN105031350A (en) | Traditional Chinese medicine for treating hypertensive heart disease and preparation method for traditional Chinese medicine | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN103285220B (en) | Traditional Chinese medicine for treating hypertension | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HU KEDING Effective date: 20140616 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315318 NINGBO, ZHEJIANG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140616 Address after: 226200 chemical industry park, Nantong, Qidong, Jiangsu Patentee after: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Address before: 315318 Wu Meicun, Henghe Town, Cixi, Zhejiang Patentee before: Hu Keding |